Diabetes and prognosis in older persons with colorectal cancer

British Journal of Cancer

Volumn 110, Issue 7, 2014, Pages 1847-1854

  Luo, J ^a   Lin, H C ^a   He, K ^a   Hendryx, M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

colorectal cancer; diabetes; prognosis

Indexed keywords

AGED; ALGORITHM; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SPECIFIC SURVIVAL; COLORECTAL CANCER; DATA BASE; DEATH; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; VERY ELDERLY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; DISEASE ASSOCIATION;

ANTINEOPLASTIC AGENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84897577064     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.68     Document Type: Article

References (49)

1. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23): 2754-2764.
2. Bella F, Minicozzi P, Giacomin A, Crocetti E, Federico M, de Leon MP, Fusco M, Tumino R, Mangone L, Giuliani O, Budroni M, Sant M (2013) Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients. J Cancer Res Clin Oncol 139(8): 1303-1310.
3. Berster JM, Goke B (2008) Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 114(1): 84-98.
4. Call R, Grimsley M, Cadwallader L, Cialone L, Hill M, Hreish V, King ST, Riche DM (2010) Insulin-carcinogen or mitogen? Preclinical and clinical evidence from prostate, breast, pancreatic, and colorectal cancer research. Postgrad Med 122(3): 158-165.
5. CCW Chronic Condition Data Warehouse (2013) https://www.ccwdata.org/web/ guest/condition-categories.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5): 373-383.
7. Chen CQ, Fang LK, Cai SR, Ma JP, Yang GX, Yang W, Zhan WH, He YL (2010) Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chinese Med J-Peking 123(21): 3084-3088.
8. CMS (2012) http://www.cms.gov/MedicareGenInfo/Vol.
9. Cossor FI, Adams-Campbell LL, Chlebowski RT, Gunter MJ, Johnson K, Martell RE, McTiernan A, Simon MS, Rohan T, Wallace RB, Paulus JK (2013) Diabetes, metformin use, and colorectal cancer survival in postmenopausal women. Cancer Epidemiol 37(5): 742-749.
10. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS (2009) Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 32(2): 287-294.
11. Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT (2012) Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30(1): 53-59.
12. Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL (2011) Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol 174(7): 860-870.
13. Extermann M (2003) Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control 10(6): 463-468.
14. Fine JP, Grey RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446): 496-509.
15. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7): 1674-1685.
16. Gorina Y, Kramarow EA (2011) Identifying chronic conditions in Medicare claims data: evaluating the Chronic Condition Data Warehouse algorithm. Health Services Res 46(5): 1610-1627.
17. Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME (2006) Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54(12): 1898-1904.
18. Hebert PL, Engelgau MM, Geiss LS, Tierney E, Riley G, Mcbean AM (1998) Identifying diabetes in the Medicare population using Medicare claims data. Diabetes 47: A187-A187.
19. Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14(15): 1707-1723.
20. Huang CW, Sun LC, Shih YL, Tsai HL, Chen CW, Yeh YS, Ma CJ, Huang CJ, Wang JY (2012) The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer. World J Surg Oncol 10: 76.
21. Huang YC, Lin JK, Chen WS, Lin TC, Yang SH, Jiang JK, Chang SC, Lan YT, Wang HS, Liu CY, Yang YW, Teng HW (2011) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137(2): 211-220.
22. Jeon JY, Jeong DH, Park MG, Lee JW, Chu SH, Park JH, Lee MK, Sato K, Ligibel JA, Meyerhardt JA, Kim NK (2013) Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs rectal cancer. Plos One 8(2): e55196.
23. Jullumstro E, Kollind M, Lydersen S, Edna TH (2009) Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol 48(3): 361-367.
24. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D (2007) A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17(8): 584-590.
25. Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12): 1258-1267.
26. Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97(22): 1679-1687.
27. Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH, Kim WH (2012) The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer 131(3): 752-759.
28. McBean AM, Yu XH (2007) The underuse of screening services among elderly women with diabetes. Diabetes Care 30(6): 1466-1472.
29. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson 3rd AB, Fuchs CS (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21(3): 433-440.
30. Morss AS, Edelman ER (2007) Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem 282(19): 14635-14644.
31. Noh GY, Hwang DY, Choi YH, Lee YY (2010) Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol 26(6): 424-428.
32. Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prevent 30(5): 466-472.
33. Putter H, Fiocco M, Geskus RB (2007) Tutorial in biostatistics: competing risks and multi-state models. Stat Med 26(11): 2389-2430.
34. Richardson LC, Pollack LA (2005) Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2(1): 48-53.
35. SEER (2012a) http://seer.cancer.gov/about/
36. SEER (2012b) http://seer.cancer.gov/statfacts/html/colorect.html.
37. Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B (2008) Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: A case-control study. Digest Dis Sci 53(9): 2486-2494.
38. Smiechowski B, Azoulay L, Yin H, Pollak MN, Suissa S (2013) The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus. Cancer Epidemiol Biomarkers Prevent 22(10): 1877-1883.
39. Stein KB, Snyder CF, Barone BB, Yeh HC, Peairs KS, Derr RL, Wolff AC, Brancati FL (2010) Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 55(7): 1839-1851.
40. van de Poll-Franse LV, Haak HR, Coebergh JWW, Janssen-Heijnen MLG, Lemmens VEPP (2012) Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia 55(8): 2163-2172.
41. van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, Dercksen MW, Coebergh JWW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120(9): 1986-1992.
42. Walker JJ, Brewster DH, Colhoun HM, Fischbacher CM, Lindsay RS, Wild SH. SDRN SDRN (2013) Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007). Diabetologia 56(7): 1531-1541.
43. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB (2002a) Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40(8): 55-61.
44. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002b) Overview of the SEER-Medicare data-content, research applications, and generalizability to the United States elderly population. Med Care 40(8): 3-18.
45. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002c) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl): IV-3-18.
46. Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Ame J Epidemiol 147(9): 816-825.
47. Wolbers M, Koller MT, Witteman JC, Steyerberg EW (2009) Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 20(4): 555-561.
48. Yang Y, Mauldin PD, Ebeling M, Hulsey TC, Liu B, Thomas MB, Camp ER, Esnaola NF (2013) Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer 119(8): 1512-1520.
49. Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, Kip KE (2011) Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care 34(10): 2323-2328.